Other
Abdominal Pain
39
Pipeline Programs↗
6
Active Trials↗
23
Companies Involved↗
Abdominal pain is a moderately active landscape with 39 programs across 23 companies. The most active players are Boehringer Ingelheim, Arena Pharmaceuticals, Portuguese Oncology Institute, Coimbra. 16 therapies are approved with 8 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical5
Phase 29
Phase 38
Analysis
Trial Status
33
clinical trials
Completed19 · 58%
Terminated6 · 18%
Recruiting4 · 12%
Withdrawn2 · 6%
Active, not recruiting1 · 3%
Not yet recruiting1 · 3%
Clinical Trials
Trial Activity
33 trials
Morphine in Acute Abdominal Pain
Completed·—·Phase 4·NCT01112540
Buscopan Versus Acetaminophen for Acute Abdominal Pain in Children
Completed·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·Phase 3·NCT02582307·236 enrolled
Is Chronic Abdominal Pain in Pediatric Patients Due to Small Intestinal Bacterial Overgrowth?
Completed·—·N/A·NCT00619970·115 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)